Almirall’s H1 2024 Outcomes: Almirall Delivers Robust Efficiency within the First Half of 2024, Reaching Web Gross sales Progress of 6.7% Pushed by Its European Dermatology Business and Accelerating Biologics By Investing.com
Robust progress trajectory maintained with Web Gross sales improve of 6.7% to…
